Clinical Trial

Chronic Hypertension and Acetyl Salicylic Acid in Pregnancy

Study acronym: CHASAP
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
A randomized clinical trial to assess the efficiency of acetylsalicylic acid (aspirin) 150 mg/day started before 20 weeks of gestation in the prevention on maternal and fœtal complications in pregnant women with chronic hypertension.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2020-04-21; most recent amendment 2026-06-11.
Status change: Not Yet Recruiting → Recruiting 2021-02-15
Trial Details
NCT Number NCT04356326
Lead Sponsor Centre Hospitalier Intercommunal Creteil
Conditions Chronic Hypertension Complicating Pregnancy, Pre-Eclampsia, Intrauterine Growth Restriction, Aspirin, Perinatal Death, Placental Abruption
Enrollment 500 participants
Start Date 2021-02-15
Primary Completion 2029-02-28 (estimated)
Study Completion 2030-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-12